AbCellera Results Presentation Deck

2020 BUSINESS UPDATE. PARTNERSHIP BUSINESS MODEL ACCELERATE DISCOVERY. SHARE IN THE SUCCESS. target PARTNER BIOTECH, PHARMA ABCELLERA mAb Pre-clinical DISCOVERY RESEARCH FEES Near-term revenue from research payments (capital efficient) Phase 1 Phase 2 Phase 3 Approval Building a diversified portfolio of milestones & royalties (primary value driver) MILESTONES Multimillion dollar potential clinical and commercial milestone payments + ROYALTIES Ab Cellera Commercial Sale Majority of risk-adjusted value from royalty on commercial therapeutic sales COPYRIGHT ABCELLERA 5

View entire presentation